V5 Ultimate
Guide

ISPE GAMP RDI: A Practical Records & Data Integrity Programme You Can Defend

The ISPE GAMP Records & Data Integrity (RDI) Good Practice Guide is the industry's most operational interpretation of the data integrity expectations published by MHRA (2018), FDA (2018), WHO (TRS 1033 Annex 4), PIC/S PI 041, and EU GMP Chapter 4 / Annex 11. Where the regulators describe what good looks like, the GAMP RDI guide tells you how to actually build it — across paper, hybrid and fully electronic records, across GxP and non-GxP boundaries, and across the full data lifecycle from generation to retention and disposal. This guide unpacks the ALCOA+ principles in the way an inspector reads them, walks through audit trail review at industrial scale, addresses the messy reality of hybrid records and spreadsheet-based GxP processes, and lays out a 60-day path to an RDI programme that survives both an MHRA inspection and your own QA's monthly review. Written for QA directors, validation leads, IT quality and data integrity officers at pharma, biotech, medical-device, and radiopharmaceutical manufacturers.

Start free trial Free trial, no credit card, onboard in days, not months.

ALCOA+ read the way an inspector reads it

ALCOA+ is the spine of every modern data integrity citation. Attributable: every record ties to a uniquely identified person and a timestamp from a trusted clock. Legible: human and machine-readable for the full retention period, including the metadata that gives the record meaning. Contemporaneous: captured at the time of the activity, not reconstructed end-of-shift from notebooks or memory. Original: the first capture (or a true certified copy) is preserved, not the transcribed summary. Accurate: the record reflects what actually happened, with the calculations and rounding rules documented. Complete: all data including reprocessed, failed, and out-of-spec results are retained — the deleted-injection scandal lives here. Consistent: the sequence of events is recorded in true chronological order across all systems involved. Enduring: retained on durable media for the regulated retention period (typically batch life + 1 year, or the longer of contract/statutory). Available: retrievable on demand for review, audit and inspection within the inspection window. The GAMP RDI guide is structured around exactly these nine attributes, with worked examples for each.

The data lifecycle — and where it actually breaks

GAMP RDI breaks the data lifecycle into six explicit phases: generation, processing, review, reporting, retention and disposal. Each phase has its own failure modes, and most data integrity citations occur at the transitions. Generation breaks when instruments are uncontrolled (shared logins, unlocked audit trails, manual overrides). Processing breaks when raw data is exported to Excel and the integrity controls are dropped at the export boundary. Review breaks when audit trail review is theoretical — signed off without being looked at. Reporting breaks when CoAs and batch records aggregate values without traceability back to source. Retention breaks when records are migrated, format-shifted or moved to lower-tier storage without an integrity check. Disposal breaks when records are destroyed before the retention period closes or after a hold notice has been raised. The GAMP RDI guide explicitly maps each phase to inspectable evidence: who, what, when, on what system, against what SOP, and where the audit trail review is recorded.

Audit trail review at industrial scale

MHRA, FDA and PIC/S PI 041 all expect routine, risk-based audit trail review for GxP critical systems — and almost no inspector accepts 'we review trails when we investigate deviations' as evidence of routine review. The GAMP RDI guide is unambiguous: define what events warrant review (changes to critical parameters, overrides, deletions, OOS reprocessing, user privilege changes), define the cadence (per-batch for QC release-impacting systems, monthly or quarterly for lower-risk systems), define the reviewer (independent of the data generator), and capture the review itself as a controlled record. The pragmatic challenge is volume: a modern LIMS or MES produces thousands of audit trail events per shift, and human review of every event is neither feasible nor required. The guide endorses risk-based filtering and exception-based review — but the rules, thresholds, and the rationale for them must be documented and validated.

Hybrid records — the most-cited failure mode

A hybrid record is one where part lives in an electronic system and part on paper (or in an uncontrolled spreadsheet) — and where neither part is the complete record on its own. Hybrid records dominate FDA 483s and EU GMP deficiencies because they are easy to create accidentally (instrument prints raw data to a chromatogram while the integration parameters live in a paper logbook) and almost impossible to defend without a written hybrid-record policy. The GAMP RDI guide requires: a documented inventory of hybrid records, an explicit definition of which medium is the original raw data, a cross-reference mechanism (electronic record references the paper logbook entry by ID and vice versa), and a retention policy that covers both media for the full period. The strategic answer is to eliminate hybrid records over time — but the tactical answer for the records you have today is rigorous policy plus an inspectable hybrid-record register.

Spreadsheets in GxP — the silent integrity gap

Excel is the most commonly used GxP application that no one validates. The GAMP RDI guide treats spreadsheet-based calculations the same as any other computerised system: classify under GAMP 5 (typically Category 5 because of bespoke macros), validate the formulas and locked cells against intended use, control versions, restrict modification rights, and capture the audit trail of every change. Realistically, the right answer for high-volume or high-risk spreadsheet processes is to migrate them into validated systems (LIMS, eQMS, MES). For the spreadsheets that remain, the controls must include: a locked validated template, a controlled change process, periodic re-validation, and — critically — the discipline that the validated spreadsheet is the original record, not a transcription of a paper original.

Data governance — roles, ownership and accountability

GAMP RDI insists that data integrity is owned, not aspired to. The guide names four roles that must exist (regardless of titles): the Data Owner (accountable for a defined data domain — e.g. analytical QC data — and its lifecycle controls), the System Owner (accountable for the computerised system that holds the data), the Process Owner (accountable for the business process that generates and consumes the data), and the QA Data Integrity Lead (independent oversight, programme governance, periodic effectiveness review). Each role has explicit deliverables: the Data Owner approves retention rules and access policies, the System Owner approves the validation state and periodic review, the Process Owner signs off the SOP linking data capture to the process, and the QA Data Integrity Lead approves the RDI programme and reports to senior management on its effectiveness. Without named roles, data integrity becomes IT's problem — which is precisely the failure mode regulators have been calling out for a decade.

Backup, archive and the long-tail of retrieval

ALCOA+ Enduring and Available together require that records remain retrievable in their original meaning for the full retention period — which for batch records can be 30+ years. GAMP RDI separates two distinct activities that companies routinely conflate: backup (operational restore from recent storage, measured in days to weeks) and archive (long-term preservation, format migrations, integrity verification). Both must be validated. Both must be tested. Backup tests prove you can restore last week's data within the recovery time objective. Archive tests prove you can render and review a 10-year-old chromatogram including its raw data and metadata. The classic failure is the company that has perfect daily backups but cannot open a 2014 CDS file because the vendor dropped support — and the records are GxP-relevant for another decade.

Cloud, SaaS and shared responsibility

For cloud-hosted GxP systems, GAMP RDI requires an explicit shared-responsibility matrix: who is accountable for which control (encryption at rest, key management, backup integrity, audit trail retention, data residency, security incident response, breach notification timelines). The matrix is not optional — both MHRA and FDA inspectors have begun asking for it by name. The vendor's SOC 2 attestation and ISO 27001 certificate are necessary but not sufficient: you still need the matrix that maps the controls to your regulated processes and your validation file. The same applies to supplier-managed multi-tenant audit trails: if the vendor manages the audit trail database, you must have contractual and technical assurance that you can retrieve your audit trail for any inspection, including during a contract dispute.

Connecting RDI to GAMP 5, Annex 11 and Part 11

GAMP RDI does not replace GAMP 5, Annex 11 or 21 CFR Part 11 — it sits on top of them. GAMP 5 covers how you validate the system; Annex 11 and Part 11 cover what controls the system must implement for electronic records and signatures; RDI covers how you operate the system over its full lifecycle to keep the records defensible. An audit-ready RDI programme cross-references all three: the validation file (GAMP 5), the electronic-record controls register (Annex 11 / Part 11), and the RDI operational evidence (audit trail review, hybrid-record register, periodic data-integrity effectiveness review). When an inspector pulls a thread on one record, the three documents should converge on the same answer.

A 60-day path to a defensible RDI programme

Days 1 to 10: appoint the QA Data Integrity Lead and document the four governance roles; complete a hybrid-record inventory and a GxP spreadsheet inventory. Days 11 to 25: rank systems by data-integrity risk (criticality of data, volume, complexity, regulatory exposure); for the top tier, define audit trail review filters, cadence, and reviewers, and capture the rationale. Days 26 to 40: validate the audit trail review against three weeks of real data to confirm the filters surface what they should; close the gaps in the validation file (Annex 11 controls register, retention rules per record class). Days 41 to 55: run a mock inspection on one tier-one system — pull a record, walk the inspector through GAMP 5 validation, Annex 11 / Part 11 controls, and RDI operational evidence; capture the gaps and close them. Days 56 to 60: present the RDI programme effectiveness metrics to senior management and book the next quarterly review. Most companies see citations drop and inspection prep time collapse from weeks to days by month four.

Where this lives in V5 Ultimate

The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.

Frequently asked

Is ISPE GAMP RDI mandatory?
Not in itself — it is industry guidance, not regulation. But MHRA, FDA, PIC/S and WHO inspectors routinely cite expectations that the GAMP RDI guide operationalises (ALCOA+, audit trail review, hybrid-record control, lifecycle data governance). In practice, an RDI programme that follows GAMP RDI gives you a defensible answer to almost every data integrity question an inspector can ask, including the ones that don't have a single regulatory anchor.
How is ALCOA+ different from ALCOA?
ALCOA (Attributable, Legible, Contemporaneous, Original, Accurate) is the original FDA framing. ALCOA+ adds Complete, Consistent, Enduring and Available to address the lifecycle gaps the original five didn't cover — particularly the loss of integrity across system boundaries, during migrations, and over long retention periods. EU GMP Chapter 4 and PIC/S PI 041 both use ALCOA+ explicitly.
Do we need to review every audit trail event?
No — and trying to is a sign of an unvalidated review process. GAMP RDI endorses risk-based, exception-based review: define the events that warrant review (overrides, deletions, OOS reprocessing, privilege changes, changes to critical parameters), filter to those events, and review the filtered set on a documented cadence. The filters and thresholds must themselves be validated and periodically re-justified.
What's the right retention period for GxP records?
It depends on the record class and jurisdiction. EU GMP requires batch records for at least one year after expiry (Chapter 4); FDA cGMP requires one year after distribution or expiry (whichever is longer); medical-device records under 21 CFR 820.180 are retained for the expected life of the device or two years from distribution, whichever is longer; ISO 13485 mirrors that. Always check the longer of statutory, contractual and product-life requirements — and freeze disposal under any active hold notice.
Are spreadsheets allowed in GxP?
Yes, but they must be validated, controlled and treated as computerised systems under GAMP 5. The pragmatic answer is to migrate high-risk, high-volume calculations into validated systems; for the spreadsheets that remain, you need a locked validated template, controlled change, restricted modification rights, and an audit trail of every save. The spreadsheet is then the original record, not a transcription.
What is a hybrid record and why is it risky?
A hybrid record is one where part of the record lives electronically and part on paper, and neither part is complete on its own. Hybrid records dominate FDA 483s because the cross-references break, the retention policies don't cover both media equally, and the 'original raw data' question becomes ambiguous. GAMP RDI requires an inventory, a written policy declaring which medium is the original, mandatory cross-reference fields, and a retention rule that covers both sides.
Does our cloud vendor's SOC 2 cover our RDI obligations?
Partially — a SOC 2 Type II covers the vendor's controls over availability, security and confidentiality, but it does not by itself satisfy your RDI obligations. You still need a shared-responsibility matrix mapping the vendor's controls and your controls to GAMP RDI and to your regulated processes, a documented validation file, and contractual assurance that audit trails and records are retrievable on demand for the full retention period.
How often should we run an RDI effectiveness review?
GAMP RDI and PIC/S PI 041 both expect a periodic, documented RDI effectiveness review reported to senior management — at least annually, more often for organisations with recent citations, active CAPAs, or major system changes. The review should cover open findings, audit trail review compliance, hybrid-record register changes, training completion, and any data integrity incidents and their root causes.

See it on your shop floor.

Free trial, no credit card, onboard in days, not months.

Editorial·Reviewed against the V5 marketing knowledge base. Spot something off? .